We are a technology-enabled pharmaceutical company leveraging the power of AI to revolutionize small molecule drug discovery. Our team invented the use of deep learning for structure-based drug design, a core technology of Atomwise’s best-in-class AI discovery engine, which is differentiated by its ability to find and optimize novel chemical matter. We have extensively validated its discovery engine, having demonstrated the ability to find compounds with therapeutic potential hundreds of times across a wide variety of protein types and multiple “hard to drug” targets. We are advancing a proprietary pipeline of small-molecule drug candidates. Our goal is to invent a better way to discover drugs that help patients.